EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing

Cas Mosterd iD, Sylvain Moineau iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26052005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Cas Mosterd und 1 weiteren Autor:innen. Beteiligte Einrichtung: Département de Biochimie, de Microbiologie et de Bio-Informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC G1V 0A6, Canad…. Hauptthemen laut MEDLINE: Streptococcus mutans, Gene Editing, CRISPR-Cas Systems, CRISPR-Associated Protein 9. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council, Natural Sciences and Engineering Research Council of Canada (Discovery Program), T1 Canada Research Chair in Bacteriophages.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR-Cas is an adaptive immune system found in bacteria and archaea that provides resistance against invading nucleic acids. Elements of this natural system have been harnessed to develop several genome editing tools, including CRISPR-Cas9. This technology relies on the ability of the nuclease Cas9 to cut DNA at specific locations directed by a guide RNA. In addition, the nuclease activity of Cas9 requires the presence of a short nucleotide motif (5′-NGG-3′ for Cas9 from Streptococcus pyogenes) called PAM, flanking the targeted region. As the reliance on this PAM is typically strict, diverse Cas9 variants recognising different PAM motifs have been studied to target a broader range of genomic sites. In this study, we assessed the potential of Cas9 from Streptococcus mutans strain P42S (SmutCas9) in gene editing. SmutCas9 recognises the rarely targeted 5′-NAA-3′ and 5′-NGAA-3′ PAMs. To test its efficacy, two genes of the virulent lactococcal phage p2 were edited, thereby demonstrating the potential of SmutCas9 for gene editing purposes, particularly in AT-rich genomes. Sequencing of total RNA also revealed the RNA components of this system, allowing further molecular characterisation of the type II-A CRISPR-Cas system of S. mutans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus mutansGene EditingCRISPR-Cas SystemsCRISPR-Associated Protein 9RNA, BacterialGenome, BacterialRNA, Guide, CRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPR-Cas9Lactococcus cremorisPAMStreptococcus mutansbacteriophagegenome editing

Substanzen

CRISPR-Associated Protein 9RNA, Guide, CRISPR-Cas SystemsRNA, Bacterial

Autor:innen und Institutionen

  • Département de Biochimie, de Microbiologie et de Bio-Informatique, Faculté des Sciences et de Génie, Université Laval, Quebec City, QC G1V 0A6, Canada.

ORCID-Profile: Cas Mosterd, Sylvain Moineau

Förderung

  • Natural Sciences and Engineering Research Council
  • Natural Sciences and Engineering Research Council of Canada (Discovery Program)
  • T1 Canada Research Chair in Bacteriophages

Zitieren

APA

Mosterd, C., & Moineau, S. (2025). Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26052005

Vancouver

Mosterd C, Moineau S. Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26052005

BibTeX
@article{Mosterd2025,
  author = {Mosterd, Cas and Moineau, Sylvain},
  title = {Insight into crRNA Processing in Streptococcus mutans P42S and Application of SmutCas9 in Genome Editing},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26052005}
}
Kostenlos starten →